Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHIFFMAN K")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1

Export

Selection :

  • and

LOGICAL PROBLEMS WITH PROKASY'S ASSESSMENT OF CONTINGENCY RELATIONS IN CLASSICAL SKIN CONDUCTANCE CONDITIONING.FUREDY JJ; POULOS CX; SCHIFFMAN K et al.1975; BEHAV. RES. METHODS INSTRUMENT; U.S.A.; DA. 1975; VOL. 7; NO 6; PP. 521-523; BIBL. 10 REF.Article

Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factorMCNEEL, D. G; SCHIFFMAN, K; DISIS, M. L et al.Blood. 1999, Vol 93, Num 8, pp 2653-2659, issn 0006-4971Article

Dynamic condylar screw: a new deviceSCHATZKER, J; MAHOMED, N; SCHIFFMAN, K et al.Journal of orthopaedic trauma. 1989, Vol 3, Num 2, pp 124-132, issn 0890-5339Article

Hemangiopericytoma of the median nerveSCHIFFMAN, K. L; HARRIS, D. C. M; HOOPER, G et al.The Journal of hand surgery (St. Louis, Mo.). 1988, Vol 13, Num 1, pp 75-78, issn 0363-5023Article

Antigen-specific recall urticaria to a peptide-based vaccineRINN, K; SCHIFFMAN, K; OTERO, H. O et al.Journal of allergy and clinical immunology. 1999, Vol 104, Num 1, pp 240-242, issn 0091-6749Article

Immunotherapeutic approaches for the treatment of breast cancerKNUTSON, K. L; SCHIFFMAN, K; RINN, K et al.Journal of mammary gland biology and neoplasia. 1999, Vol 4, Num 4, pp 353-365, issn 1083-3021Article

Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunizationDISIS, M. L; SCHIFFMAN, K; GOOLEY, T. A et al.Clinical cancer research. 2000, Vol 6, Num 4, pp 1347-1350, issn 1078-0432Article

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancerDEMIRER, T; ROWLEY, S; BUCKNER, C. D et al.Journal of clinical oncology. 1995, Vol 13, Num 7, pp 1714-1719, issn 0732-183XArticle

Progress towards standardisation of ball crateringGEE, M. G; GANT, A; HUTCHINGS, I et al.Wear. 2003, Vol 255, Num 1, pp 1-13, issn 0043-1648, 13 p.Conference Paper

Results from an interlaboratory exercise to validate the micro-scale abrasion testGEE, M. G; GANT, A. J; PLINT, G et al.Wear. 2005, Vol 259, Num 1, pp 27-35, issn 0043-1648, 9 p.Conference Paper

Factors that influence collection and engraftment of autologous peripheral-blood stem cellsBENSINGER, W; APPELBAUM, F; CLIFT, R et al.Journal of clinical oncology. 1995, Vol 13, Num 10, pp 2547-2555, issn 0732-183XArticle

Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaSCHIFFMAN, K; CLIFT, R; WEIDEN, P et al.Bone marrow transplantation (Basingstoke). 1993, Vol 11, Num 3, pp 227-232, issn 0268-3369Article

Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem in patients with acute myelogeneous leukemiaDEMIRER, T; BUCKNER, C. D; SCHIFFMAN, K et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 6, pp 915-922, issn 0268-3369Article

Phase II study of high-dose busulfan, melphalan and thiotepa with autologous blood stem cell support in patients with malignant diseaseSCHIFFMAN, K. S; BENSINGER, W. I; GOOLEY, T et al.Bone marrow transplantation (Basingstoke). 1996, Vol 17, Num 6, pp 943-950, issn 0268-3369Article

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerBENSINGER, W. I; SCHIFFMAN, K. S; ROWLEY, S et al.Bone marrow transplantation (Basingstoke). 1997, Vol 19, Num 12, pp 1183-1189, issn 0268-3369Article

High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaBENSINGER, W. I; ROWLEY, S. D; CHAUNCEY, T et al.Journal of clinical oncology. 1996, Vol 14, Num 5, pp 1447-1456, issn 0732-183XArticle

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphomaWEAVER, C. H; PETERSEN, F. B; BENYUNES, K et al.Journal of clinical oncology. 1994, Vol 12, Num 12, pp 2559-2566, issn 0732-183XArticle

High-dose fractionated total-body irradiation etoposide and cyclophosphamide for treatment of malignant lymphoma : comparison of autologous bone marrow and peripheral blood stem cellsBRUNVAND, M. W; BENSINGER, W. I; FEFER, A et al.Bone marrow transplantation (Basingstoke). 1996, Vol 18, Num 1, pp 131-142, issn 0268-3369, 11 p.Article

  • Page / 1